Santaris Pharma A/S has announced that it has completed a EUR 40m ($58.8mm) private investment round. The proceeds of the financing will be used primarily to fund continued development of Santaris Pharma’s portfolio of innovative drug candidates based on LNA (Our unique RNA Antagonist, based on the RNA analogue, Locked Nucleic Acid), including SPC2996, an […]
Less
More
UltraCell Corporation - a manufacturer of micro fuel cell systems for portable devices. BASF said that it would provide $3 million (£1.53 million), which will go towards a total of $10.3 million raised by UltraCell in its Series C financing round. BASF identified energy management, including the development of new energy storage and conversion technology, […]
Symphogen announced today that it has raised 5 million Euro (6.5 million USD) from Dutch venture capital fund Gilde Healthcare Partners. This investment is an addition to Symphogen’s last financing round and brings the company’s total amount of money raised to 85 million USD. Symphogen is the leader in developing recombinant polyclonal antibodies (pAb), […]
Serious, Inc: Greenhill SAVP announced today that it has made a $5 million investment in Serious, Inc. as part of a $14 million round of financing. Serious, based in New York, is a privately held provider of digital publishing and marketing services (they make gift cards that double as CDs) Serious’ portfolio of intellectual property […]
rPath Continues Momentum with Addition of $9.1M in Funding rBuilder Online (rBO), rPath’s community for developers, grew to over 250,000 downloads in 2006. With over 5,000 projects and 8,000 users, the community has become the most active catalog for software and virtual appliances in the industry. rBuilder Online offers software and virtual appliances […]
Quick Study Radiology Inc. said Tuesday that it has raised $3.3 million in venture capital to ramp up sales and take advantage of growing interest in its digital imaging technology. QSR sells Internet-based storage, access and security systems for digital imaging files such as X-rays and CT scans.
Prosensa Holding B.V., a Netherlands based Biotechnology Company focused on RNA interference therapeutics using exon skipping technology, today announced that it has a signed agreement for $18 million (EUR 13.5 million) in financing. The Company is focused on developing a medicine for DMD (Duchenne Muscular Dystrophy).
Farecast has landed $12.1 million that the Seattle online travel startup will use to roll out its airfare predictions for international destinations and expand into new travel categories such as hotels
Brilliant Telecommunications (Brilliant), Inc., a developer of ultra precise and reliable Network Timing Protocol (NTP) server technology, based on advanced hardware and software, announced the company had secured $7.1 million in Series A funding Brilliant Telecommunications designs and develops an intelligent family of highly accurate and reliable network time protocol servers which deliver timing […]
Aperto Networks, builder of the world’s most advanced WiMAX base stations and subscriber units, announced today that it had completed a follow-on Series E financing round of $19 million, bringing the company’s total capitalization to $139 million
Misc Sectors